0001209191-17-065297.txt : 20171212 0001209191-17-065297.hdr.sgml : 20171212 20171212201439 ACCESSION NUMBER: 0001209191-17-065297 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171208 FILED AS OF DATE: 20171212 DATE AS OF CHANGE: 20171212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kroll Werner CENTRAL INDEX KEY: 0001609320 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 171252862 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-12-08 0 0000353569 QUIDEL CORP /DE/ QDEL 0001609320 Kroll Werner 12544 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130 0 1 0 0 SVP, R&D Common Stock 2017-12-08 4 M 0 7100 23.41 A 10818 D Common Stock 2017-12-08 4 S 0 7100 40.4856 D 3718 D Common Stock 2017-12-08 4 M 0 9258 23.41 A 12976 D Common Stock 2017-12-08 4 S 0 9258 40.4063 D 3718 D Non-Qualified Stock Option 23.41 2017-12-08 4 M 0 7100 0.00 D 2017-02-05 2025-02-05 Common Stock 7100 26854 D Non-Qualified Stock Option 23.41 2017-12-08 4 M 0 9258 0.00 D 2017-02-05 2025-02-05 Common Stock 9258 17596 D The weighted average sale price for these transactions was $40.485564 per share, with a range of $40.40 to $40.62. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. The weighted average sale price for these transactions was $40.406319 per share, with a range of $40.36 to $40.45. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Robert J. Bujarski, attorney-in-fact for Werner Kroll 2017-12-12